FDA Approves Lurbinectedin Combo for ES-SCLC Maintenance

The approval is for a first-line combination maintenance therapy for extensive-stage SCLC.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-approves-lurbinectedin-combo-es-sclc-maintenance-2025a1000qnn?src=rss

Author :

Publish date : 2025-10-03 19:10:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

FDA Approves Lurbinectedin Combo for ES-SCLC Maintenance

Benefit of Dual Antiplatelet Therapy Murky in Valve-in-Valve Intervention

FDA Approves Maintenance Combo for Small Cell Lung Cancer

Related Posts

JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis

‘If That Doesn’t Blow Your Mind’: What We Heard This Week

Tirzepatide-Hormone Therapy Combo Tied to Weight Loss in Postmenopausal Women

Prevention Has a Branding Problem

Pool Data Back Safety of Newly Approved Non-Hormonal Treatment for Hot Flashes

What Vaccine Was Tied to Longer Cancer Survival?

JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis

‘If That Doesn’t Blow Your Mind’: What We Heard This Week

Tirzepatide-Hormone Therapy Combo Tied to Weight Loss in Postmenopausal Women

Prevention Has a Branding Problem

Pool Data Back Safety of Newly Approved Non-Hormonal Treatment for Hot Flashes

What Vaccine Was Tied to Longer Cancer Survival?

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Categories

Archives